Group #1: Jamie Newman (USA); Guilherme Barcellos (Brazil); Andrés Aizman (Chile); Fernando Rivera (USA); Luiz Rojas Orellana (Chile); Neil Winawer (USA); Esteban Gandara (Canada); Jairo Roa (Colombia)

Group#2 (2010-now): Guilherme Barcellos (Brazil); Jamie Newman (USA); Andrés Aizman (Chile); Daniel Grassi (Argentina); Fernando Rivera (USA); Luiz Rojas Orellana (Chile); Roberto Daniel Martinez (Argentina); Lucas Zambon (Brazil); Neil Winawer (USA); Esteban Gandara (Canada); Fabiana Rolla (Brazil)

Saturday, February 26, 2011

Winawer speaks about Pan American Hospital Medicine

Listen and comment

Thursday, February 24, 2011

Jamie speaks about Pan American Hospital Medicine issues. Listen and comment

"It took many years to Hospital Medicine to grow in the USA. It has taken ten years to be a full specialty. At first there was only a few hundred doctors doing it and people thought it wouldn’t last, and now there is tens of thousand hospitalists in the USA, it is a huge growth. But it took five or six to start really growing and in the last three or four to really expand. It is a ten year process!"

Tuesday, February 22, 2011

Mark Enzler's impression about the PASHA2010

Listen and comment

Sunday, February 20, 2011

From the Brazilian National Health Surveillance Agency about the PASHA2010

What did the Brazilian National Health Surveillance Agency (Anvisa) think about the PASHA2010?

  (in Portuguese)

ANVISA is linked to the Ministry of Health. The institutional purpose of the agency is to foster protection of the health of the population by exercising sanitary control over production and marketing of products and services subject to sanitary surveillance. The agency has additional attributions: coordination of the National Sanitary Surveillance System (SNVS), the National Program of Blood and Blood Products and the National Program of Prevention and Control of Hospital Infections; monitoring of drug prices and prices of medical devices.

Eddie Greene, Mayo Clinic nefrologist, speaks about the PASHA2010

Listen and comment

Friday, February 18, 2011

PASHA2010 from a fifth-year medical student from Universidade Positivo, Curitiba, Brazil point of view

The meeting, held in November at a beautiful beach resort in Florianópolis in southern Brazil, was pioneering in several aspects...

PASHA2010: An Argentine perspective

Daniel Grassi speaks about the meeting and about the Hospital Medicine in Argentina. Listen and comment.

Aleta Borrud speaks about the PASHA2010

Aleta Borrud, Mayo Clinic hospitalist, speaks about the PASHA2010, about the evolution that she observes between the moment of the first big meeting about HM in Brazil (I Brazilian Congress of Hospital Medicine, 2008) and now. Borrud compares aspects of the North American and the South American movement and speaks about the decision of not having pharmaceutical industry funding for the PASHA2010. Listen and comment.


Tuesday, February 1, 2011

Will we be replaced by hospitalist “midlevel” providers?

Considering the fact that some hospital administrators have a tendency to view hospitalists as floaters who fill in for other physicians.

We know that the role of the hospitalist is more than being on-site as a “super resident” processing patients for other physicians or as a “nurse's doctor of convenience”, but...
Brazil is champion in absolute number of medical schools and we have a profession in crisis: too many doctors - lots of dysfunctional competition - low salaries;

In Brazil we can’t use midlevel providers.

My fear in that [bad] hospitals in Brazil start to use young licensed doctors as “midlevel hospitalists”. A physician assistant in the US is a healthcare professional licensed to practice medicine with supervision of a licensed physician. There is a movement here to have a licensed physician (not medical resident anymore) working for hospitals and attending physicians giving rear to the traditional model. Some hospitalist programs start because of the increasing necessity of around-the-clock doctors at the hospitals, but to be just for the attending physicians’ temporary substitution, what adds another layer of costs, perhaps duplication...

Will we be replaced by hospitalist “midlevel” providers?

Hope comments could help us...